Author : Abd-Alhammid, Shaimaa N.
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 2, Pages 23-30
Development of the dosage form aimed for safe, effective and easy administration
according to that ideal way is the oral route, but great challenges stop against that like
poor absorption, enzymatic degradation, low solubility and gastric effect all these
barriers present in the GIT. Intestinal patch with it is a unique design, consist of
protective and mucoadhesive parts resemble transdermal patch that provide good
chance for developing an oral dosage form to the proteins, peptides, aminoglycoside
and low permeable drugs near look about this oral intestinal device in this review.